PharmGen Science Inc (004720) — Cash Flow Reinvestment Rate
PharmGen Science Inc (004720) has a Cash Flow Reinvestment Rate of 0.78x as of September 2025, reinvesting ₩1.48 Billion (capex ₩799.96 Million plus investments ₩-680.92 Million) from operating cash flow of ₩1.91 Billion. Explore reinvestment intensity of PharmGen Science Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PharmGen Science Inc Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for PharmGen Science Inc across 10 annual periods. Also explore 004720 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for PharmGen Science Inc (2011–2024)
Year-by-year capital reinvestment analysis for PharmGen Science Inc. For live market cap and broader valuation context, see PharmGen Science Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.54x | ₩3.67 Billion | ₩2.38 Billion | ₩2.78 Billion | ▲ +74.9% |
| 2023 | 0.88x | ₩4.79 Billion | ₩5.44 Billion | ₩3.29 Billion | ▼ -78.7% |
| 2021 | 4.14x | ₩32.25 Billion | ₩7.78 Billion | ₩30.75 Billion | ▲ +126.7% |
| 2020 | 1.83x | ₩4.89 Billion | ₩2.68 Billion | ₩4.34 Billion | ▼ -55.8% |
| 2019 | 4.14x | ₩10.44 Billion | ₩2.52 Billion | ₩6.16 Billion | ▲ +84.6% |
| 2018 | 2.24x | ₩9.45 Billion | ₩4.22 Billion | ₩892.34 Million | ▲ +161.2% |
| 2017 | 0.86x | ₩1.58 Billion | ₩1.84 Billion | ₩1.54 Billion | ▼ -65.4% |
| 2016 | 2.48x | ₩19.26 Billion | ₩7.75 Billion | ₩3.43 Billion | ▲ +123.6% |
| 2015 | 1.11x | ₩4.02 Billion | ₩3.62 Billion | ₩771.87 Million | ▲ +400.3% |
| 2011 | 0.22x | ₩642.43 Million | ₩2.89 Billion | ₩642.43 Million | — |